Listening
Episodes
One search box across the whole catalog, titles and show notes alike. It earns its keep when you half-remember a case, a device or a name and want the conversation it came up in.
5,508 episodes · 33 shows
Audio unavailableThe Niche Episode 028 – CAR T ON/OFF, Fujifilm, Affinivax, IconOVir, Lexeo Therapeutics
Turning CAR T on and off, Fujifilm’s $2 billion investment, Affinivax raises $226 million, and startups to watchSponsorshttps://www.thescopemethod.com Story References10.1126/scitranslmed.abb6295https://affinivax.com/affinivax-announces-226…
- Audio unavailable
The Niche Episode 027 – WHO, AstraZeneca, Phitonex, Axsome
AstraZeneca and W.H.O., vaccine I-told-you-so’s, Phitonex acquired by ThermoFisher, and Axsome reports success in migraine relief. Sponsorshttps://www.thescopemethod.comStory Referenceshttps://www.rttnews.com/3157074/astrazeneca-s-covid-19-…
- Audio unavailable
The Niche Episode 026 – Top Trends from 2020
Trends in science from investors and immune-oncology to decentralized trials and basic research, we look back on 2020Sponsorshttps://www.thescopemethod.comStory Referenceswww.thenichepod.comMusic by Luke Goodsonhttps://www.soundcloud.com/lu…
- Audio unavailable
The Niche Episode 025 – COVID, ERT & Bioclinica, Philips & BioTelemetry, AR Surgery
COVID updates, ERT & Bioclinica merge, Philips acquires BioTelemetry, and augmented reality surgeries. Sponsorshttps://www.thescopemethod.comStory Referenceshttps://www.ellumehealth.com/2020/12/15/fda-authorizes-ellume-covid-19-home-tes…
- Audio unavailable
The Niche Episode 024 – Vaccine EAU, 70+ IPOs, Gilead
Vaccines are here, capitalizing on capital with IPOs, and Gilead targets Hepatitis D. Sponsorshttps://www.thescopemethod.comStory Referenceshttps://www.fda.gov/news-events/press-announcements/fda-takes-key-action-fight-against-covid-19-issu…
- Audio unavailable
The Niche Episode 023 – Everlywell, Bayer + Atara, and Moderna
Everlywell expands at-home testing, Bayer and Atara strike deal, and Moderna heads to the FDA. Sponsorshttps://www.thescopemethod.comStory Referenceshttps://www.prnewswire.com/news-releases/everlywell-announces-175-million-financing-to-expa…
- Audio unavailable
The Niche Episode 022 – Interview with COVID19 Survivor
This week, we take a thanksgiving break from the news cycle to bring you a special interview with a COVID survivor and healthcare worker, Trenton Barrick. He shares an inside perspective on the healthcare industry as well as his personal ex…
- Audio unavailable
The Niche Episode 021 – Pfizer, mRNA Vaccine Function, and Novartis + Mesoblast
Pfizer submits to the FDA, how mRNA vaccines work, and Novartis drops a billion, but really only $50 million Story Referenceshttps://www.biospace.com/article/pfizer-and-biontech-to-submit-covid-19-vaccine-to-fda-for-emergency-use-today/http…
- Audio unavailable
The Niche Episode 020 – Vaccines, NightWare, Agios, Silverback
COVID19 vaccine news, an app to stop nightmares, Agios targets Sickle Cell disease, and Silverback files to go public. Sponsorshttps://www.thescopemethod.com Story Referenceshttps://www.pfizer.com/news/press-release/press-release-detail/pfi…
- Audio unavailable
The Niche Episode 019 – Biogen, Novo Nordisk, and Merck
Aducanumab skeptics, Novo Nordisk and Merck make acquisitions, but first a market update.Sponsorshttps://www.thescopemethod.com Story References https://www.sciencemag.org/news/2020/11/biogen-s-alzheimer-s-drug-candidate-takes-beating-fda-a…
- Audio unavailable
The Niche Episode 018 – Syneos Health, Apellis, and Patient Enrollment
Syneos Health acquires Synteract, Apellis strikes a billion-dollar deal, and clinical trial patient enrollment, but first a market update.Sponsorshttps://www.thescopemethod.com Story Referenceshttps://www.investor.syneoshealth.com/news-rele…
- Audio unavailable
The Niche Episode 017 – Covance, IQVIA, ThermoFisher, Convalescent Plasma, Remdesivir
This week, siteless with vision, IQVIA back on track, 36%, convalescent plasma, and Remdesivir approved. Sponsors https://www.thescopemethod.com Story References https://www.businesswire.com/news/home/20201020005645/en/LabCorp-Transforms-th…
- Audio unavailable
The Niche Episode 016 – Slow, Sickle-Cell, CRO Mergers, Praxis IPO, Wasp Venom
Failures in sickle-cell therapy, CRO mergers in Asia, Praxis IPO, and wasp venom.Sponsors https://www.thescopemethod.com Story References https://ir.cyclerion.com/news-releases/news-release-details/cyclerion-announces-phase-2-strong-scd-stu…
- Audio unavailable
The Niche Episode 015 – CRISPR, Tinnitus, Takeda, and Political-Science
Nobel prizes, clinical trials for tinnitus, Takeda’s billion-dollar deal, and the White House keeps science politicalSponsorshttps://www.thescopemethod.com Story Referenceshttps://www.nobelprize.org/prizes/chemistry/2020/summary/https://stm…
- Audio unavailable
The Niche Episode 014 – Bristol Myers, Trump, NIH, and Sophia Genetics
Bristol Myers strikes a $13 billion deal, presidential experiments, the NIH funds under-represented testing, and Sophia Genetics raises $110 million. Sponsorshttps://www.thescopemethod.com Story Referenceshttps://www.businesswire.com/news/h…
- Audio unavailable
The Niche Episode 013 – Alzheimer’s, COVID19, AKG, Vitamin D, and Gene Therapy
Another Alzheimer’s failure, COVID19 updates, two stories in the supplements space, and Taysha goes public. Sponsors https://www.thescopemethod.com Story References https://ir.acimmune.com/news-releases/news-release-details/ac-immune-report…
- Audio unavailable
The Niche Episode 012 – Probiotics, Lipid Nanoparticles, Transparency, and Immuno-therapy
Finch does probiotics the expensive way, lipid nanoparticles, a followup on transparency, and LAVA gains immuno-therapy support.Sponsorshttps://www.thescopemethod.com Story Referenceshttps://www.businesswire.com/news/home/20200916005915/en/…
- Audio unavailable
The Niche Episode 011 – AstraZeneca, Satsuma Pharmaceuticals, and Orasis Pharmaceuticals
This week, vaccines and shark statistics, are noses the ultimate pipedream, and eye drops to replace eye-glasses. Sponsors https://www.thescopemethod.com Story References https://www.astrazeneca.com/content/astraz/media-centre/press-release…
- Audio unavailable
The Niche Episode 010 – Roche, Abbvie, I-Mab, BioNTech, Pfizer, PPD & Lupus
Roche earns FDA approval for a combined flu/COVID diagnostic, I-Mab signs with Abbvie for $2 billion, PPD partners to treat lupus, and BioNTech/Pfizer add more COVID candidates while Moderna adds bad press.Sponsorswww.thescopemethod.com Sto…
- Audio unavailable
The Niche Episode 009 – Healthcare is Politics
This week, we take a break from our normal news cycle to focus on one big idea; healthcare is politics. But first, a quick update.Sponsorswww.thescopemethod.com Story Referenceshttps://www.sec.gov/Archives/edgar/data/1620463/000156459020041…
- Audio unavailable
The Niche Episode 008 – J&J, Momenta, White House, FDA, Decentralized Trials
Johnson & Johnson acquires Momenta, the White House and FDA disagree, and the emergence of decentralized clinical trial management.Sponsorswww.thescopemethod.comStory Referenceshttps://www.momentapharma.com/investors-and-news/press-rele…
- Audio unavailable
The Niche Episode 007 – Samsung Biologics, Moderna (again), Microparticles, and Qiagen
Samsung Biologics builds big, Modern (again), microparticles for timed-release chemotherapy, and Qiagen says ‘no’ to acquisitions.Sponsorswww.thescopemethod.com Story Referenceshttps://samsungbiologics.com/front/en/mediaCenter/pressReleases…
- Audio unavailable
The Niche Episode 006 – Biogen, Denali, US Drugs, and Parasitic Sexual Partners
Biogen and Denali partner for Parkinson’s, the US pushes American-based drug manufacturing, and the secret to Parasitic Sexual Partners uncovered.Sponsorswww.thescopemethod.com Story Referenceshttps://investors.biogen.com/news-releases/news…
- Audio unavailable
The Niche Episode 005 – Vaccines Reach Warp Speed, Merck, and Tecartus Approved
We review a few of the big winners from operation warp speed, Merck continues to be quietly successful, and a new CAR T treatment, Tecartus, gets FDA approval. Sponsorswww.thescopemethod.com Story Referenceshttps://s21.q4cdn.com/488056881/f…